 |
| Professor John Wilson AM is using gene-product modulating therapy for treatment of patients with cystic fibrosis |
Gene-product modulating therapy – treatment addressing gene abnormality by acting on the proteins arising from the gene rather than trying to correct the gene itself – has been attracting considerable scientific attention in recent years.
Monash University’s Professor John Wilson AM, who is using this approach to treat patients with cystic fibrosis, recently reported on the therapy in a comment piece published in Gene Therapy Nature.
